• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在肺部立体定向体部放疗中,边缘处方等同于等中心处方:日本临床肿瘤学组试验(JCOG1408)的初步研究

Marginal prescription equivalent to the isocenter prescription in lung stereotactic body radiotherapy: preliminary study for Japan Clinical Oncology Group trial (JCOG1408).

作者信息

Kawahara Daisuke, Ozawa Shuichi, Kimura Tomoki, Saito Akito, Nishio Teiji, Nakashima Takeo, Ohno Yoshimi, Murakami Yuji, Nagata Yasushi

机构信息

Section of Radiation Therapy, Department of Clinical Support, Hiroshima University Hospital 1-2-3, Kasumi, Minami-ku, Hiroshima 734-8551, Japan.

Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima 734-8551, Japan.

出版信息

J Radiat Res. 2017 Jan;58(1):149-154. doi: 10.1093/jrr/rrw096. Epub 2016 Oct 19.

DOI:10.1093/jrr/rrw096
PMID:28115532
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5321195/
Abstract

A new randomized Phase III trial, the Japan Clinical Oncology Group (JCOG) 1408, which compares two dose fractionations (JCOG 0403 and JCOG 0702) for medically inoperable Stage IA NSCLC or small lung lesions clinically diagnosed as primary lung cancer, involves the introduction of a prescribed dose to the D of the planning target volume (PTV) using a superposition/convolution algorithm. Therefore, we must determine the prescribed dose in the D prescribing method to begin JCOG1408. JCOG 0702 uses density correction and the D prescribing method. However, JCOG 0403 uses no density correction and isocenter- prescribing method. The purpose of this study was to evaluate the prescribed dose to the D of the PTV equivalent to a dose of 48 Gy to the isocenter (JCOG 0403) using a superposition algorithm. The peripheral isodose line, which has the highest conformity index, and the D of the PTV were analyzed by considering the weighting factor, i.e. the inverse of the difference between the doses obtained using the superposition and Clarkson algorithms. The average dose at the isodose line of the highest conformity index and the D of the PTV were 41.5 ± 0.3 and 42.0 ± 0.3 Gy, respectively. The D of the PTV had a small correlation with the target volume (r = 0.0022) and with the distance between the scatterer and tumor volumes (r = 0.19). Thus, the prescribed dose of 48 Gy using the Clarkson algorithm (JCOG0403) was found to be equivalent to the prescribed dose of 42 Gy to the D of the PTV using the superposition algorithm.

摘要

一项新的随机III期试验——日本临床肿瘤学组(JCOG)1408,比较了两种剂量分割方案(JCOG 0403和JCOG 0702)用于医学上无法手术的IA期非小细胞肺癌或临床诊断为原发性肺癌的小肺病变,该试验涉及使用叠加/卷积算法将处方剂量引入计划靶体积(PTV)的D。因此,我们必须确定D处方方法中的处方剂量以启动JCOG1408。JCOG 0702使用密度校正和D处方方法。然而,JCOG 0403不使用密度校正,而是采用等中心处方方法。本研究的目的是使用叠加算法评估与等中心剂量48 Gy(JCOG 0403)等效的PTV的D的处方剂量。通过考虑加权因子,即使用叠加算法和克拉克森算法获得的剂量之差的倒数,分析了具有最高适形指数的外周等剂量线和PTV的D。最高适形指数的等剂量线处的平均剂量和PTV的D分别为41.5±0.3和42.0±0.3 Gy。PTV的D与靶体积(r = 0.0022)以及散射体与肿瘤体积之间的距离(r = 0.19)的相关性较小。因此,发现使用克拉克森算法(JCOG0403)的48 Gy处方剂量与使用叠加算法的PTV的D的42 Gy处方剂量等效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fbc/5321195/45b96bfeef27/rrw096f06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fbc/5321195/8136a16c39df/rrw096f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fbc/5321195/38aa4813c0a7/rrw096f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fbc/5321195/3db34336a6b8/rrw096f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fbc/5321195/4ab836b6a5ac/rrw096f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fbc/5321195/08864c7919d4/rrw096f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fbc/5321195/45b96bfeef27/rrw096f06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fbc/5321195/8136a16c39df/rrw096f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fbc/5321195/38aa4813c0a7/rrw096f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fbc/5321195/3db34336a6b8/rrw096f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fbc/5321195/4ab836b6a5ac/rrw096f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fbc/5321195/08864c7919d4/rrw096f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fbc/5321195/45b96bfeef27/rrw096f06.jpg

相似文献

1
Marginal prescription equivalent to the isocenter prescription in lung stereotactic body radiotherapy: preliminary study for Japan Clinical Oncology Group trial (JCOG1408).在肺部立体定向体部放疗中,边缘处方等同于等中心处方:日本临床肿瘤学组试验(JCOG1408)的初步研究
J Radiat Res. 2017 Jan;58(1):149-154. doi: 10.1093/jrr/rrw096. Epub 2016 Oct 19.
2
A modified formula for dose calculations of stereotactic ablative body radiotherapy for non-small cell lung cancer.一种用于非小细胞肺癌立体定向消融体部放射治疗剂量计算的修正公式。
Med Dosim. 2018;43(3):207-213. doi: 10.1016/j.meddos.2017.08.008. Epub 2017 Oct 6.
3
A randomized Phase III trial of comparing two dose-fractionations stereotactic body radiotherapy (SBRT) for medically inoperable Stage IA non-small cell lung cancer or small lung lesions clinically diagnosed as primary lung cancer: Japan Clinical Oncology Group Study JCOG1408 (J-SBRT trial).一项比较两种剂量分割的立体定向体部放疗(SBRT)用于医学上无法手术的IA期非小细胞肺癌或临床诊断为原发性肺癌的小肺部病变的随机III期试验:日本临床肿瘤学组研究JCOG1408(J-SBRT试验)。
Jpn J Clin Oncol. 2017 Mar;47(3):277-281. doi: 10.1093/jjco/hyw198. Epub 2017 Jan 9.
4
Difference in dose-volumetric data between the analytical anisotropic algorithm, the dose-to-medium, and the dose-to-water reporting modes of the Acuros XB for lung stereotactic body radiation therapy.用于肺部立体定向体部放射治疗的Acuros XB在分析各向异性算法、介质剂量和水剂量报告模式之间的剂量-体积数据差异。
J Appl Clin Med Phys. 2016 Sep 8;17(5):341-347. doi: 10.1120/jacmp.v17i5.6338.
5
Adapted Prescription Dose for Monte Carlo Algorithm in Lung SBRT: Clinical Outcome on 205 Patients.肺部立体定向放疗中蒙特卡罗算法的适应性处方剂量:205例患者的临床结果
PLoS One. 2015 Jul 24;10(7):e0133617. doi: 10.1371/journal.pone.0133617. eCollection 2015.
6
Comparison of pencil beam-based homogeneous vs inhomogeneous target dose planning for stereotactic body radiotherapy of peripheral lung tumors through Monte Carlo-based recalculation.通过基于蒙特卡洛的重新计算比较基于笔形束的均匀与非均匀靶区剂量规划在外周型肺肿瘤立体定向体部放疗中的应用
Med Dosim. 2015 Autumn;40(3):248-55. doi: 10.1016/j.meddos.2015.02.001. Epub 2015 Mar 14.
7
Dose distribution analysis in stereotactic body radiotherapy using dynamic conformal multiple arc therapy.立体定向体部放射治疗中使用动态适形多弧治疗的剂量分布分析
Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):363-9. doi: 10.1016/j.ijrobp.2008.08.012.
8
Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plans.剂量计算算法对生物优化的IMRT肺部立体定向体部放射治疗计划的放射生物学影响。
Radiat Oncol. 2016 Jan 22;11:10. doi: 10.1186/s13014-015-0578-2.
9
Dosimetric differences between local failure and local controlled non-small cell lung cancer patients treated with stereotactic body radiotherapy: A matched-pair study.立体定向体部放疗治疗局部复发与局部控制的非小细胞肺癌患者的剂量学差异:一项配对研究。
J Med Imaging Radiat Oncol. 2018 Jun;62(3):420-424. doi: 10.1111/1754-9485.12706. Epub 2018 Feb 5.
10
Treatment planning for lung cancer: traditional homogeneous point-dose prescription compared with heterogeneity-corrected dose-volume prescription.
Int J Radiat Oncol Biol Phys. 2003 Aug 1;56(5):1308-18. doi: 10.1016/s0360-3016(03)00337-7.

引用本文的文献

1
Investigation of factors related to treatment planning of x-ray SBRT and scanning carbon-ion radiation therapy for early-stage lung cancer patients.早期肺癌患者X射线立体定向体部放疗和扫描碳离子放射治疗的治疗计划相关因素研究。
J Appl Clin Med Phys. 2025 Apr;26(4):e14618. doi: 10.1002/acm2.14618. Epub 2025 Feb 11.
2
Prognostic Factors of Oligometastasis After Stereotactic Body Radiotherapy: The Real-World Utility of the European Society for Radiotherapy and Oncology/European Organisation for Research and Treatment of Cancer Classification.立体定向体部放疗后寡转移的预后因素:欧洲放射治疗与肿瘤学会/欧洲癌症研究与治疗组织分类在真实世界中的应用
Cureus. 2024 May 19;16(5):e60590. doi: 10.7759/cureus.60590. eCollection 2024 May.
3

本文引用的文献

1
Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403.立体定向体部放疗治疗可手术和不可手术 T1N0M0 期非小细胞肺癌的前瞻性研究:日本临床肿瘤学组研究 JCOG0403。
Int J Radiat Oncol Biol Phys. 2015 Dec 1;93(5):989-96. doi: 10.1016/j.ijrobp.2015.07.2278. Epub 2015 Nov 11.
2
Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer with PTV<100 cc using a continual reassessment method (JCOG0702).采用连续评估法(JCOG0702)研究立体定向体部放疗治疗外周 T2N0M0 期非小细胞肺癌,PTV<100cc 的 I 期研究。
Radiother Oncol. 2015 Aug;116(2):276-80. doi: 10.1016/j.radonc.2015.07.008. Epub 2015 Jul 29.
3
Stereotactic ablative body radiotherapy with a central high dose using CyberKnife for metastatic lung tumors.立体定向消融体部放射治疗联合 CyberKnife 中央高剂量治疗肺转移瘤。
BMC Cancer. 2023 Mar 7;23(1):215. doi: 10.1186/s12885-023-10635-6.
4
Stereotactic body radiation therapy for metastatic lung metastases.立体定向体部放射治疗转移性肺转移瘤。
Jpn J Radiol. 2022 Oct;40(10):995-1005. doi: 10.1007/s11604-022-01323-9. Epub 2022 Sep 13.
5
Relationship between Dose Prescription Methods and Local Control Rate in Stereotactic Body Radiotherapy for Early Stage Non-Small-Cell Lung Cancer: Systematic Review and Meta-Analysis.早期非小细胞肺癌立体定向体部放射治疗中剂量处方方法与局部控制率的关系:系统评价与Meta分析
Cancers (Basel). 2022 Aug 5;14(15):3815. doi: 10.3390/cancers14153815.
6
Development of a high-resolution two-dimensional detector-based dose verification system for tumor-tracking irradiation in the CyberKnife system.基于高分辨率二维探测器的 CyberKnife 系统肿瘤追踪放疗剂量验证系统的研制。
J Appl Clin Med Phys. 2022 Aug;23(8):e13645. doi: 10.1002/acm2.13645. Epub 2022 Jul 5.
7
Dosimetric Evaluation of Simplified Knowledge-Based Plan with an Extensive Stepping Validation Approach in Volumetric-Modulated Arc Therapy-Stereotactic Body Radiotherapy for Lung Cancer.基于简化知识的计划在容积调强弧形放疗-立体定向体部放疗治疗肺癌中的剂量学评估及广泛的步进验证方法
J Med Phys. 2021 Jan-Mar;46(1):7-15. doi: 10.4103/jmp.JMP_67_20. Epub 2021 May 5.
8
Prolonged overall treatment time negatively affects the outcomes of stereotactic body radiotherapy for early-stage non-small-cell lung cancer: A propensity score-weighted, single-center analysis.立体定向体部放疗治疗早期非小细胞肺癌时,过长的总治疗时间对预后有负面影响:倾向评分加权的单中心分析。
PLoS One. 2021 Jun 18;16(6):e0253203. doi: 10.1371/journal.pone.0253203. eCollection 2021.
9
Ten-Year Experience of Stereotactic Body Radiotherapy at a Single Institution: Impact of Technological Development on the Outcome of Patients With Early Lung Cancer.单一机构 10 年立体定向体部放疗经验:技术发展对早期肺癌患者结局的影响。
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820979163. doi: 10.1177/1533033820979163.
10
An overview of the medical-physics-related verification system for radiotherapy multicenter clinical trials by the Medical Physics Working Group in the Japan Clinical Oncology Group-Radiation Therapy Study Group.日本临床肿瘤学会-放射治疗研究组医学物理工作组对放疗多中心临床试验中与医学物理相关的验证系统的概述。
J Radiat Res. 2020 Nov 16;61(6):999-1008. doi: 10.1093/jrr/rraa089.
Correlation between target volume and electron transport effects affecting heterogeneity corrections in stereotactic body radiotherapy for lung cancer.肺癌立体定向体部放射治疗中靶区体积与影响不均匀性校正的电子传输效应之间的相关性。
J Radiat Res. 2014 Jul;55(4):754-60. doi: 10.1093/jrr/rrt231. Epub 2014 Feb 11.
4
Dose calculation differences between Monte Carlo and pencil beam depend on the tumor locations and volumes for lung stereotactic body radiation therapy.对于肺部立体定向体部放射治疗,肿瘤位置和体积的不同会导致蒙特卡罗法和笔形束算法之间的剂量计算存在差异。
J Appl Clin Med Phys. 2013 Mar 4;14(2):4011. doi: 10.1120/jacmp.v14i2.4011.
5
Differences in the dose-volume metrics with heterogeneity correction status and its influence on local control in stereotactic body radiation therapy for lung cancer.异质性校正状态下剂量-体积学指标的差异及其对肺癌立体定向体部放疗局部控制的影响。
J Radiat Res. 2013 Mar 1;54(2):337-43. doi: 10.1093/jrr/rrs084. Epub 2012 Sep 14.
6
Dosimetric verification using monte carlo calculations for tissue heterogeneity-corrected conformal treatment plans following RTOG 0813 dosimetric criteria for lung cancer stereotactic body radiotherapy.使用蒙特卡罗计算对肺癌立体定向体部放射治疗 RTOG 0813 剂量学标准下组织不均匀性校正的适形治疗计划进行剂量验证。
Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):508-13. doi: 10.1016/j.ijrobp.2011.12.005. Epub 2012 Feb 24.
7
Evaluation of heterogeneity dose distributions for Stereotactic Radiotherapy (SRT): comparison of commercially available Monte Carlo dose calculation with other algorithms.立体定向放射治疗(SRT)的不均匀剂量分布评估:商业可用的蒙特卡罗剂量计算与其他算法的比较。
Radiat Oncol. 2012 Feb 9;7:20. doi: 10.1186/1748-717X-7-20.
8
The management of tumor motions in the stereotactic irradiation to lung cancer under the use of Abches to control active breathing.立体定向放疗肺癌中应用 Abdes 控制主动呼吸时的肿瘤运动管理。
Med Phys. 2011 Jul;38(7):4141-6. doi: 10.1118/1.3604151.
9
Clinical introduction of Monte Carlo treatment planning: a different prescription dose for non-small cell lung cancer according to tumor location and size.蒙特卡罗治疗计划的临床介绍:根据肿瘤位置和大小为非小细胞肺癌制定不同的处方剂量。
Radiother Oncol. 2010 Jul;96(1):55-60. doi: 10.1016/j.radonc.2010.04.009. Epub 2010 Apr 27.
10
Co-morbidity index predicts for mortality after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer.合并症指数预测立体定向体部放疗治疗不能手术的早期非小细胞肺癌患者的死亡率。
Radiother Oncol. 2009 Dec;93(3):402-7. doi: 10.1016/j.radonc.2009.06.002. Epub 2009 Jun 24.